# Neuphoria Therapeutics Inc.: Form 6-K, filed Mar 15, 2024

- Company: [Neuphoria Therapeutics Inc.](/companies/neup.md) (CIK 1191070)
- Form: 6-K
- Filed: 2024-03-15
- Accepted by EDGAR: Mar 15, 2024, 10:06 ET
- Period: 2024-03-15
- Accession: 0000950170-24-031859
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1191070/000095017024031859/bionomics_-_6k_hye_2024.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1191070/000095017024031859/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1191070/000095017024031859/bionomics_-_6k_hye_2024.htm

Filed Mar 15, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-031859. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.